Eton Pharmaceuticals (ETON) Return on Capital Employed (2018 - 2026)
Eton Pharmaceuticals (ETON) posted Return on Capital Employed of 1.41% for Q4 2025, up 68.98% sequentially from 4.55% in Q3 2025, and up 580.0% YoY from 0.21% in Q4 2024.
Eton Pharmaceuticals (ETON) Return on Capital Employed (2018 - 2026) Analysis & Trends
Eton Pharmaceuticals has reported Return on Capital Employed for 8 years, with the latest figure at 1.41% in Q4 2025.
- Quarterly Return on Capital Employed rose 580.0% year-over-year to 1.41% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 1.41% (up 580.0% YoY) and the FY2025 annual result came in at 1.85%, up 579.0% from the prior year.
- Return on Capital Employed advanced to 1.41% in Q4 2025 per ETON's latest filing, from 4.55% in the prior quarter.
- Over five years, Return on Capital Employed peaked at 8.94% in Q3 2023 and troughed at 56.76% in Q2 2022.
- A 5-year average of 24.1% and a median of 20.67% in 2023 frame the typical range for Return on Capital Employed.
- The sharpest annual moves came in 2021 and 2024: Return on Capital Employed surged 18434 bps in 2021, then sank 4596 bps in 2024.
- Over 5 years, Return on Capital Employed stood at 6.65% in 2021, then plunged by 639 bps to 49.13% in 2022, then surged by 84 bps to 7.74% in 2023, then increased by 7 bps to 7.21% in 2024, then surged by 80 bps to 1.41% in 2025.
- According to Business Quant data, Return on Capital Employed over the past three periods registered 1.41%, 4.55%, and 1.49% for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 6.60% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 17.16% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 6.07% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 22.04% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -0.29% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 18.67% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 5.52% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Eton Pharmaceuticals | 1.65 Bn | 1.62 Bn | 25.41 Mn | 21.11% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 21.11% |
| Dec 31, 2025 | -1.41% |
| Sep 30, 2025 | -4.55% |
| Jun 30, 2025 | -1.49% |
| Mar 31, 2025 | -4.14% |
| Dec 31, 2024 | -7.21% |
| Sep 30, 2024 | -37.02% |
| Jun 30, 2024 | -47.94% |
| Mar 31, 2024 | 3.39% |
| Dec 31, 2023 | -7.74% |
| Sep 30, 2023 | 8.94% |
| Jun 30, 2023 | -2.71% |
| Mar 31, 2023 | -33.60% |
| Dec 31, 2022 | -49.13% |
| Sep 30, 2022 | -45.44% |
| Jun 30, 2022 | -56.76% |
| Mar 31, 2022 | -54.67% |
| Dec 31, 2021 | -6.65% |
| Sep 30, 2021 | -44.68% |
| Jun 30, 2021 | -38.83% |